105 related articles for article (PubMed ID: 17158039)
1. Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds.
Goddeeris C; Coacci J; Van den Mooter G
Eur J Pharm Biopharm; 2007 May; 66(2):173-81. PubMed ID: 17158039
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
3. Development of SMEDDS using natural lipophile: application to beta-Artemether delivery.
Mandawgade SD; Sharma S; Pathak S; Patravale VB
Int J Pharm; 2008 Oct; 362(1-2):179-83. PubMed ID: 18652886
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin.
Zhang P; Liu Y; Feng N; Xu J
Int J Pharm; 2008 May; 355(1-2):269-76. PubMed ID: 18242895
[TBL] [Abstract][Full Text] [Related]
6. Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: impact on solubility and drug release.
Goddeeris C; Goderis B; Van den Mooter G
Eur J Pharm Sci; 2010 May; 40(2):110-7. PubMed ID: 20298780
[TBL] [Abstract][Full Text] [Related]
7. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.
Bolko K; Zvonar A; Gašperlin M
Drug Dev Ind Pharm; 2014 Jan; 40(1):102-9. PubMed ID: 23301796
[TBL] [Abstract][Full Text] [Related]
8. High-throughput formulation screening system for self-microemulsifying drug delivery.
Sakai K; Maeda H; Yoshimori T; Obata K; Ogawa Y
Drug Dev Ind Pharm; 2009 Jun; 35(6):746-55. PubMed ID: 19514991
[TBL] [Abstract][Full Text] [Related]
9. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
11. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
Fatouros DG; Bergenstahl B; Mullertz A
Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
[TBL] [Abstract][Full Text] [Related]
12. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
13. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
Djekic L; Primorac M
Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipase-catalyzed hydrolysis of emulsified triglyceride oils by low-molecular weight surfactants under simulated gastrointestinal conditions.
Li Y; McClements DJ
Eur J Pharm Biopharm; 2011 Oct; 79(2):423-31. PubMed ID: 21443951
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions.
Li P; Ghosh A; Wagner RF; Krill S; Joshi YM; Serajuddin AT
Int J Pharm; 2005 Jan; 288(1):27-34. PubMed ID: 15607255
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus.
Attama AA; Nkemnele MO
Int J Pharm; 2005 Nov; 304(1-2):4-10. PubMed ID: 16198521
[TBL] [Abstract][Full Text] [Related]
17. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
[TBL] [Abstract][Full Text] [Related]
18. Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of alpha-tocopherol self-emulsified drug delivery systems (SEDDS).
Ali H; Nazzal M; Zaghloul AA; Nazzal S
Int J Pharm; 2008 Mar; 352(1-2):104-14. PubMed ID: 18065173
[TBL] [Abstract][Full Text] [Related]
19. Development and characterisation of a self-microemulsifying drug delivery systems (SMEDDSs) for the vaginal administration of the antiretroviral UC-781.
McConville C; Friend D
Eur J Pharm Biopharm; 2013 Apr; 83(3):322-9. PubMed ID: 23159711
[TBL] [Abstract][Full Text] [Related]
20. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
